Literature DB >> 9785858

Changes in plasma free and sulfoconjugated dopamine in patients with congenital heart disease who underwent cardiac operation.

M Yoshizumi1, T Kitagawa, Y Masuda, T Hori, T Kitaichi, Y Ogawa, I Katoh, H Houchi.   

Abstract

It has been suggested that plasma sulfoconjugated dopamine (DA) may serve as a source or reservoir for free DA in plasma. Moreover, it has also been reported that the plasma levels of conjugated DA may be used as an index predicting heart failure in patients with heart disease. Therefore, in the present study, we have measured the plasma levels of free and sulfoconjugated DA in patients with congenital heart disease who underwent total corrective operations. The patients were divided into two groups with (6 patients with tetralogy of Fallot, TOF) or without (5 patients with ventricular septal defect without pulmonary hypertension, VSD) cyanosis (mean age of 2.11 years). Blood samples were collected before and after operation from the patients, and plasma free and sulfoconjugated DA levels were measured using high performance liquid chromatography. Preoperative levels of free DA in patients in both groups were higher than the level in age matched control subjects. The plasma level of conjugated DA in TOF was higher than that in the controls and was the highest in VSD before operation. DA infusion early after operation caused a rise in plasma free and conjugated DA, however, the levels of increased free DA were lower in the VSD than in the TOF group. After discontinuing DA infusion, the plasma levels of free DA remained higher, while those of conjugated DA decreased to a level lower than the preoperative values in both groups. As the plasma levels of free and sulfoconjugated DA vary with hemodynamics, it was assumed that the difference in the plasma sulfoconjugated DA level between the groups before operation was due to the influence of pulminary blood flow on catecholamine homeostasis. Since the decrease in conjugated DA has been postulated to be an index of sustained heart failure, it is conceivable that it takes a long time for patients who underwent cardiac operations in infancy to recover from heart failure.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9785858     DOI: 10.1007/bf03217797

Source DB:  PubMed          Journal:  Jpn J Thorac Cardiovasc Surg        ISSN: 1344-4964


  17 in total

1.  [Changes in plasma sulfoconjugated catecholamines during perioperative period of cardiac operations--effect of continuous infusion of dopamine].

Authors:  M Yoshizumi; I Katoh; Y Egawa; T Kitagawa; O Miki; Y Masuda; T Ohuchi; M Oka
Journal:  Nihon Kyobu Geka Gakkai Zasshi       Date:  1992-02

Review 2.  Catecholamine metabolism: basic aspects and clinical significance.

Authors:  I J Kopin
Journal:  Pharmacol Rev       Date:  1985-12       Impact factor: 25.468

3.  Physiological significance of plasma sulfoconjugated dopamine in patients with hypertension--clinical and experimental studies.

Authors:  M Yoshizumi; T Kitagawa; T Hori; I Katoh; H Houchi; T Ohuchi; M Oka
Journal:  Life Sci       Date:  1996       Impact factor: 5.037

4.  Plasma catecholamine levels in children.

Authors:  M Candito; M Albertini; S Politano; A Deville; R Mariani; P Chambon
Journal:  J Chromatogr       Date:  1993-08-11

5.  Plasma free and conjugated catecholamines in diagnosis and localisation of pheochromocytoma.

Authors:  D Ratge; G Baumgardt; E Knoll; H Wisser
Journal:  Clin Chim Acta       Date:  1983-08-31       Impact factor: 3.786

6.  Physiological significance of plasma sulfoconjugated dopamine: experimental and clinical studies.

Authors:  M Yoshizumi; Y Ishimura; Y Masuda; T Ohuchi; I Katoh; H Houchi; M Oka
Journal:  Hypertens Res       Date:  1995-06       Impact factor: 3.872

7.  Pathophysiologic significance of free and conjugated dopamines in congestive heart failure.

Authors:  Y Nakaya; T Katayama; M Nomura; Y Ishimura; T Ohuchi; M Oka; M Yamamoto; S Mizobuchi
Journal:  Am Heart J       Date:  1994-03       Impact factor: 4.749

8.  Plasma concentrations of free and sulfoconjugated dopamine, epinephrine, and norepinephrine in healthy infants and children.

Authors:  I Eichler; H G Eichler; M Rotter; P A Kyrle; S Gasic; A Korn
Journal:  Klin Wochenschr       Date:  1989-07-03

Review 9.  Clinical implications of genetic and acquired defects in catecholamine synthesis and metabolism.

Authors:  O Kuchel
Journal:  Clin Invest Med       Date:  1994-08       Impact factor: 0.825

10.  Plasma free and sulfate conjugated catecholamine levels during acute physiological stimulation in man.

Authors:  D A Joyce; L J Beilin; R Vandongen; L Davidson
Journal:  Life Sci       Date:  1982-02-01       Impact factor: 5.037

View more
  1 in total

Review 1.  Where Is Dopamine and how do Immune Cells See it?: Dopamine-Mediated Immune Cell Function in Health and Disease.

Authors:  S M Matt; P J Gaskill
Journal:  J Neuroimmune Pharmacol       Date:  2019-05-11       Impact factor: 4.147

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.